Local-scale phylodynamics reveal differential community impact of SARS-CoV-2 in a metropolitan US county.
Saved in:
| Title: | Local-scale phylodynamics reveal differential community impact of SARS-CoV-2 in a metropolitan US county. |
|---|---|
| Authors: | Paredes MI; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Perofsky AC; Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, United States of America.; Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America., Frisbie L; Washington State Department of Health, Shoreline, Washington, United States of America., Moncla LH; The University of Pennsylvania, Department of Pathobiology, Philadelphia, Pennsylvania, United States of America., Roychoudhury P; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Xie H; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Bakhash SAM; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Kong K; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Arnould I; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Nguyen TV; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Wendm ST; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Hajian P; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Ellis S; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Mathias PC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Greninger AL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Starita LM; Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, United States of America.; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America., Frazar CD; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America., Ryke E; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America., Zhong W; Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, United States of America., Gamboa L; Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, United States of America., Threlkeld M; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America., Lee J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Stone J; Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, United States of America., McDermot E; Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, United States of America., Truong M; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America., Shendure J; Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, United States of America.; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America.; Howard Hughes Medical Institute, Seattle, Washington, United States of America., Oltean HN; Washington State Department of Health, Shoreline, Washington, United States of America., Viboud C; Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America., Chu H; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, United States of America., Müller NF; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Bedford T; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, United States of America.; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America.; Howard Hughes Medical Institute, Seattle, Washington, United States of America. |
| Source: | PLoS pathogens [PLoS Pathog] 2024 Mar 26; Vol. 20 (3), pp. e1012117. Date of Electronic Publication: 2024 Mar 26 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1553-7374 |
|---|---|
| DOI: | 10.1371/journal.ppat.1012117 |
